Soy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific Antigen

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01682941
Recruitment Status : Active, not recruiting
First Posted : September 11, 2012
Last Update Posted : October 3, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Yael Vodovotz, Ohio State University Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : June 2015
  Estimated Study Completion Date : December 2018